Caricamento...
Targeted delivery of immuno-RNase may improve cancer therapy
BACKGROUND: Immunotoxins are typical therapeutic drugs that can target cancer cells. They exploit the affinity of specific monoclonal antibodies or ligands to cancer cells to deliver a conjugated protein toxin to target sites, thus, attacking the cancer cells. METHODS: The immuno-RNase, Onc-V3, show...
Salvato in:
| Pubblicato in: | Cancer Cell Int |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5902972/ https://ncbi.nlm.nih.gov/pubmed/29686536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-018-0546-7 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|